Cytograft Tissue Engineering
 
a new paradigm in revascularization
Technology

Clinical Trials

Investor Relations

Collaborators

Employment

Publications / Media

About CTE

Contact

Cytograft Tissue Engineering

has developed a proprietary technology

to build living vascular grafts exclusively

from the patient's own cells.



First Human Implant                     Cytograft in The New York Times
Technology | Investor Relations | Collaborators | Employment | Publications | Contact | Home